{"name":"Aptevo Research and Development LLC","slug":"aptevo-research-and-development-llc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"APVO436","genericName":"APVO436","slug":"apvo436","indication":"Other","status":"phase_1"}]}],"pipeline":[{"name":"APVO436","genericName":"APVO436","slug":"apvo436","phase":"phase_1","mechanism":"Biologic","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMirwFBVV95cUxPQTFqVWVqUS1WZEZQUHZreGxRNlhoemUtUWNCeHltM2JjeDJfODdqRm9WMDZTa1NCejNvcEFsbWdEc18yQVVJaEkxSGNIUWZMcGpaYWR1aFZJN1ZBSW1WbzU2aXp0a09GRUdZbVdMaTFjVFhFNnpfaGNCSUtzYURtQ2hiNFNKOGtEUGVOdi1uYW1NS3A1dV9xT2JSdzZHbUMzZnZrd1R5RHY1aUJKcWRR?oc=5","date":"2026-03-26","type":"trial","source":"Stock Titan","summary":"Aptevo Therapeutics (NASDAQ: APVO) outlines bispecific cancer pipeline and AML data - Stock Titan","headline":"Aptevo Therapeutics (NASDAQ: APVO) outlines bispecific cancer pipeline and AML data","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_1":1},"enrichmentLevel":0,"visitCount":3,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}